Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Renal Cell 11Melanoma 10Carcinoma, Hepatocellular 7Brain Neoplasms 6Leukemia, Myeloid, Acute 5Glioblastoma 5Sarcoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myelomonocytic, Acute 4Gliosarcoma 4Urinary Bladder Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 3Thyroid Neoplasms 3Rectal Neoplasms 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Neoplasms 3Multiple Myeloma 3Lymphoma, Large B-Cell, Diffuse 3Liver Neoplasms 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia, Erythroblastic, Acute 3Leukemia, Eosinophilic, Acute 3Leukemia, Basophilic, Acute 3Hemangiosarcoma 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Blast Crisis 3

Interventions

Radiotherapy 3Ifosfamide 3Doxorubicin 3Vincristine 2Neoadjuvant Therapy 2Etoposide 2Epirubicin 2Dactinomycin 2Cyclophosphamide 2Chemotherapy, Adjuvant 2Carboplatin 2romidepsin 1cixutumumab 1Temozolomide 1Sorafenib 1Peripheral Blood Stem Cell Transplantation 1Molecular Diagnostic Techniques 1Microarray Analysis 1Magnetic Resonance Spectroscopy 1Filgrastim 1Brachytherapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Hemangiopericytoma, Malignant × Sorafenib × Clear all
NCT00217620 2014-05-15

S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas

National Cancer Institute (NCI)

Phase 2 Completed
51 enrolled 9 charts
Sarcoma

Hemangiopericytoma, Malignant, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡